The microRNAs 19a and 19b, hereafter collectively referred to as miR-19a/b, were recognised to be the most important miRNAs in the oncomiRs-miR-17-92 cluster. However, the exact roles of miR-19a/b in cancers have not been elucidated. In the present study, miR-19a/b was found to be over-expressed in gastric cancer tissues and significantly associated with the patients' metastasis of gastric cancer. Using gain or loss-of-function in in vitro and in vivo experiments, a pro-metastatic function of miR19a/b was observed in gastric cancer. Furthermore, reporter gene assay and western blot showed that MXD1 is a direct target of miR-19a/b. Functional assays showed that not only MXD1 had an opposite effect to miR-19a/b 1,2 It has been firmly recognised that miRNAs regulate many key cellular processes, such as cell growth, cell cycle, differentiation and cell death. Understanding miRNA functions and transcriptional regulatory circuits requires elucidation of the molecular pathways that are responsible for specific biological phenomenon through the integration of transcription factors, miRNAs and the direct targets of miRNAs.
The microRNAs 19a and 19b, hereafter collectively referred to as miR-19a/b, were recognised to be the most important miRNAs in the oncomiRs-miR-17-92 cluster. However, the exact roles of miR-19a/b in cancers have not been elucidated. In the present study, miR-19a/b was found to be over-expressed in gastric cancer tissues and significantly associated with the patients' metastasis of gastric cancer. Using gain or loss-of-function in in vitro and in vivo experiments, a pro-metastatic function of miR19a/b was observed in gastric cancer. Furthermore, reporter gene assay and western blot showed that MXD1 is a direct target of miR-19a/b. Functional assays showed that not only MXD1 had an opposite effect to miR-19a/b in the regulation of gastric cancer cells, but also overexpression of MXD1 reduced both miR-19a/b and c-Myc levels, indicating a potential positive feedback loop among miR-19a/b, MXD1 and c-Myc. In conclusion, miR-17-92 cluster members miR-19a/b facilitated gastric cancer cell migration, invasion and metastasis through targeting the antagonist of c-Myc -MXD1, implicating a novel mechanism for the malignant phenotypes of gastric cancer. Cell Death and Disease (2014) 5, e1144; doi:10.1038/cddis.2014.110; published online 27 March 2014
Subject Category: Cancer MicroRNAs (miRNAs) are small, non-coding RNAs 19-24 nucleotides in length that act in association with the RNAinduced silencing complex to regulate expression of multiple genes by either inducing translational silencing or causing degradation of the mRNA of the targeted genes. 1, 2 It has been firmly recognised that miRNAs regulate many key cellular processes, such as cell growth, cell cycle, differentiation and cell death. Understanding miRNA functions and transcriptional regulatory circuits requires elucidation of the molecular pathways that are responsible for specific biological phenomenon through the integration of transcription factors, miRNAs and the direct targets of miRNAs. 3 More recently, miRNAs have emerged as oncogenes or tumour suppressors 4 that act as central players in networks that establish regulatory circuits in cancers. The miR-17-92 cluster, one of the miRNA clusters transcriptionally activated by the proto-oncogene c-Myc, 5 first attracted attention following a series of observations that linked these miRNAs to cancer pathogenesis; the miR-17-92 cluster was shown to be over-expressed in many cancers, including lung, colon and breast cancer and neuroblastoma. [6] [7] [8] [9] An important role for these miRNAs in the regulatory circuit that controls cellular life and the cell cycle further illustrates the contributions of these miRNAs to tumorigenesis. Specifically, the transcriptional activators E2F1 and E2F3 can directly activate the transcription of miR-17-92, and, in turn, E2F1, E2F2 and E2F3 are among the first experimentally verified targets of these miRNAs. 10 Although the miR-17-92 cluster members have been established as oncomiRs, their oncogenic contributions in cancers have not been assigned. The miR-17-92 cluster contains six members: miR-19a/b, miR-17/20a, miR-18a and miR-92a. We chose miR-19a/b for the present study because they were recently identified to be the most important miRNAs in this cluster, 11, 12 and we observed a pro-metastatic function of miR-19a/b in our primary studies. Expression of miR-19a/b was previously found to be correlated with lymph node metastasis in non-small cell lung cancer patients, 13 however, the exact roles of miR-19a/b in cancer metastasis have not been elucidated. In the present study, we aimed at exploring the relationships between miR-19a/b and metastasis, and the potential mechanisms. Using gain and loss-of-function assays, a pro-metastatic function of miR-19a/b was observed. Furthermore, the tumour suppressor MXD1 was demonstrated to be a direct target of miR-19a/b. Our findings provide mechanistic insight into the function of miR-19a/b and have important implications for understanding gastroenterological disorders resulting from altered regulation of miRNA pathways.
Results
Expression of miR-19a/b was associated with metastasis in gastric cancer patients. miR-19a/b were previously regarded as oncomiRs and were detected to regulate the self-renewal of gastric cancer stem cells in our department (data not shown). We firstly tested the expression of miR19a/b in gastric cancer tissues by real-time PCR using RNAs from 141 patients who underwent gastrectomy and were followed up at Xijing Hospital during 2006-2008. We used a log2 À DDCt analysis to statistically describe the expression levels of miR-19a/b. As shown in Figures 1a and b , the results verified that the expression of miR-19a (A) or miR-19b (B) was higher in 10 of 15 or 10 of 15 randomly selected human gastric cancer tissues, respectively, compared with the adjacent normal tissues. Interestingly, there was 13 out of 15 gastric cancer samples with either miR-19a or miR-19b overexpression from the results of the real-time PCR (Figures 1a and b) . Correlations between miR-19a/b expression levels and clinicopathologic characteristics of gastric cancer are summarised in Table 1 . A statistically significant association between miR-19a/b expression levels and metastasis of gastric cancer patients was observed in this study. The expression of miR-19a or miR-19b in gastric cancer patients did not correlate with age, gender or cell differentiation, but correlated with remote metastasis of gastric cancer patients (Po0.001). The expression of miR19a was also significantly associated with TNM stage and lymph node metastasis (Po0.001).
To examine whether the expression levels of miR-19a/b were associated with survival in the above gastric cancer patients, we ranked the patients on the basis of the relative Table 1 ).
Stable overexpression of miR-19a/b miRNAs promoted gastric cancer cell migration and invasion in vitro. Because miR-19a/b were over-expressed in gastric cancer tissues compared with normal tissues and their expression was associated with the metastasis of gastric cancer patients, we speculated that the overexpression of miR-19a/b might promote the migratory and invasive abilities of gastric cancer cells. To test the metastatic ability of miR19a/b, we constructed an EGFP-expressing lentivirus with miR-19a/b precursors or a negative control small RNA and infected them into gastric cancer cell lines SGC7901 and MKN28. The EGFP-positive cells were detected using fluorescence microscopy and were sorted using a FACS machine as indicated in Supplementary Figures 1A Table 2 . At the end of the experiment, the nude mice were sacrificed, and the lungs and livers of the nude mice were harvested, fixed and embedded in paraffin for further staining. The formation of tumours in the lungs and livers was further confirmed by H&E staining as indicated in Figure 4e .
miR-19a/b miRNAs targeted MXD1 transcript by binding the 3 0 UTR of MXD1 transcripts. In silico analysis using miRanda software (http://www.microrna.org/microrna/home.do) showed that the 3 0 -UTR of human MXD1 contains two conserved putative target sites for miR-19a/b miRNAs ( Figure 5a ). To validate these target sites, the 3 0 -UTR of human MXD1 was amplified and inserted in both orientations downstream of the luciferase gene in the pGL3-control vector, generating sense (S) and antisense (AS) constructs, collectively referred to as Luc-1 in Figure 5a . Two shorter clones (Luc-2 and Luc-3) were prepared similarly ( Figure 5a ). The transfection of SGC7901 cells with miR-19a or miR-19b precursors significantly decreased the expression of Luc-1S while having no effect on Luc-1AS expression (Figure 5b ). In contrast, no affect was observed in cells transfected with miR-150, in accordance with the fact that the MXD1 3 0 -UTR does not contain a miR-150 target site (Figure 5b ). The expression of Luc-2S was also reduced by either miR-19a or miR-19b precursors but not miR-150 (Figure 5c ). Furthermore, miR-19a and miR-19b targeted Luc-3S but not Luc-3AS, as indicated in Figure 5d . 5 cells were plated and incubated for 24 h at 37 1C. Cells invaded through to the downside of the membrane, were fixed with 100% methanol and stained with 0.2% crystal violet (**Po0.01 compared with the NC group, t-test). Each experiment was repeated at least three times. Error bars correspond to the mean ± S.D.
Overexpression of MXD1 without 3
0 UTR-impaired miR-19a/b effects. To determine the downregulating effects of miR-19a/b at the protein level, we performed western blotting assays using an anti-MXD1 antibody. As expected, the transient transfection of SGC7901 cells with pre-miR-19a or pre-miR-19b decreased MXD1 levels (Figure 5e ), while cells transiently transfected with miR-19a or miR-19b inhibitors showed increased MXD1 levels, which suggest that miR-19a/b miRNAs regulate MXD1 expression in vivo at the post-transcriptional level.
To further confirm that MXD1 is a target of miR-19a and miR-19b, we performed real-time PCR using RNAs from the 15 paired malignant and normal tissues. As shown in Figures  6a and b , expression of MXD 1 adversely correlated with both the expression of miR-19a (A, P ¼ 0.001) and miR-19b (B, P ¼ 0.009).
To further prove that MXD1 is the major player downstream of miR-19a/b, we performed migration assay using cells transfected with pre-NC, pre-miR-19a, pre-miR-19a and To test whether miR-19a and miR-19b levels were regulated by MXD1, we performed real-time PCR on MXD1 over-expressing cells or cells transfected with MXD1 siRNAs (si-MXD1). As shown in Figures 7e and f, in MXD1 overexpressing cells, the expression levels of miR-19a and miR-19b were two or threefold lower than in the vector control group (Figure 7e) . In si-MXD1 expressing cells, miR-19a and miR-19b expression levels were three to four times higher compared with the vector control group (Figure 7f) . These results demonstrated that although miR-19a/b can downregulate MXD1 expression by binding its 3 0 UTR, overexpression of MXD1 can also reduce miR-19a/b expression levels, indicating a potential miRNA target gene selfregulatory loop between miR-19a/b and MXD1.
Discussion
The human miR-17-92 cluster is located on 13q31.3, a frequently amplified locus in colorectal cancers and lymphomas. The miR-17-92 cluster members, including miR-17/20a, miR-19a/b, miR-18a and miR-92a, were identified to be over-expressed in many cancers, including breast, 6 lung, 7 pancreatic, 14 colon 8 and gastric cancer. 15, 16 Each member of the cluster is predicted to regulate a variety of different cellular targets; however, the functions of miRNAs in this cluster were still unclear. He L et al. 17 originally identified the miR-17-92 cluster as a potential human oncogene in B-cell lymphomas. Later, O Donnell et al. 5 demonstrated the transcriptional activation of the miR-17-92 cluster by the proto-oncogene c-Myc, thus establishing a potential role of this cluster in cell proliferation, growth and apoptosis. Recently, Mu et al.
11 identified miR-19a/b as the most important miRNAs of this cluster. Using deletion-reintroduction mouse models, they found that reintroduction of miR-19a/ b rescued oncogenicity but not to the same extent as reintroduction of the entire cluster, indicating the protumourigenic activity within this cluster. Using gain-of-function models, Olive et al. 12 also found that overexpression of the full cluster without miR-92 enhanced tumorigenesis, but when miR-19a and miR-19b were lost from the cluster, tumorigenesis was not enhanced, indicating the important function of miR-19 in tumorigenesis.
Although miR-19a and miR-19b were found to be the most significant miRNAs of the miR-17-92 cluster, and were reported to have a broad and significant roles in normal or abnormal cells of human body, [18] [19] [20] [21] the exact function and the potential mechanisms of them in gastric cancer has not been fully clarified. We have previously found that the expression of the miR-17-92 cluster members were gradually changed during the differentiation of gastric cancer stem cells, among the six members, miR-19b/20a/92a can regulate the selfrenewal of gastric cancer stem cells through activating the Wnt-b-catenin signalling. 22 Further study found that miR-19a/ b could sustain the multi-drug resistance of gastric cancer cells. 23 In the present study, we first observed that miR-19a/b was over-expressed in most of the randomly selected gastric cancer samples and overexpression of miR-19a and miR-19b was significantly associated with metastasis in gastric cancer patients. Furthermore, in vivo and in vitro experiments were performed to test the relationships between miR-19a/b miRNAs and metastasis in gastric cancer using both stable and transient miR-19a/b expressing cells. Moreover, a promigratory, pro-invasive and pro-metastatic effect was observed in this study using in vitro and in vivo metastatic assays, which was consistent with the previous studies that the miR-17-92 cluster acts as oncomiRs in cancers. Recently, miR-17-92 members have emerged as central players in networks that establish regulatory feedback circuits. Additionally, the targeted genes of this cluster are involved in distinct pathways so that the targeted gene may exert opposing effects. Several previous reports 5, [26] [27] [28] confirmed that the E2F transcription factor family members can induce the expression of miR-17-92, and two of these family members are direct targets of miR-17-92, which generate a negative feedback loop aimed at restricting miR-17-92 transcription levels. In another report, Tili et al. 29 discovered that GAM reduces the transcriptional activation of the miR-17-92 promoter, downregulates miR-17-92 expression and limits the activation of genes related to the TGF-b canonical pathway. In contrast, TGF-b reduces GAM transcript levels while differentially upregulating miR-17-92 expression. In turn, miR-17-92 targeted GAM transcripts, thus establishing another auto-regulatory feedback loop. In the present study, despite the relationships between miR-19a/b and MXD1, we also found that c-Myc, the transactivator of miR-19a/b, can be reduced by introducing MXD1 into gastric cancer cells. Thus, the direct link between miR-19a/b miRNAs and the c-Myc antagonist gene MXD1 demonstrated a positive feedback loop between c-Myc, miR-19a/b and MXD1 that may be useful in reducing the opposite effects. Thus, auto-regulation contributes to the sustained induction of malignancies in gastric cancer. As a last remark, the emergence of cancer coincides with a failure in regulating gene duplication, gene transcription and/ or the levels of signalling molecules involved in regular metabolism. Therefore, it is possible that a new level of molecular complexity in tumours is generated by the development of robust genetic circuitries for the maintenance of cellular dysfunction and the prohibition of the organism to adapt to changing environments. MXD1, c-Myc and the miR-19a/b miRNAs have all been shown to increase in cancers; therefore, it is not surprising that they may be implicated in the control of cancer cell progression and tumour development and that they may interact with each other in different ways. Our study implied that the positive autoregulatory network among miR-19a/b, MXD1 and c-Myc might be important in preserving the expression levels of oncogenic miRNAs and thus might provide a new viewpoint for the mechanism of the metastasis in gastric cancer. Cell culture and reagents. The human gastric adenocarcinoma cell line SGC7901 was obtained from the Academy of Military Medical Science, and MKN28 was obtained from the Shanghai Cell Bank (Shanghai, China). These two cell lines were preserved in our institute. SGC7901Luc cells stably expressing firefly luciferase were generated and preserved in our lab. All of the cells were Construction of miR-19a and miR-19b lentivirus. For miR-19a and miR-19b sequences, two PCR primers were annealed to get the inserted sequences. The lentiviral vector pGCsil-H1 was double digested, purified and directly connected with the annealed products. The products were further transformed to competent bacterial cells for the growth of colonies, which were identified using PCR to get the positive clones. Positive clones identified by PCR were sequenced and analysed. Right clones were considered to be successfully constructed miR-19a and miR-19b plasmid lentiviral vectors. After ultrapure extraction to remove the endotoxin, the vectors were packaged with lentivirus into 293T cells using Lipofectamine 2000 (Invitrogen). Lentivirus was harvested and concentrated from cells and then titre was detected using GFP expressing strength.
Lentivirus miR-19a/b infection and stable cells. The lentiviral system with EGFP-expressing miR-19a (lenti-miR-19a) and miR-19b (lenti-miR-19b) and the negative control lenti-vector (lenti-NC) were purchased from Genechem (Shanghai Genechem Co., Ltd, Shanghai, China). Gastric cancer cell lines SGC7901, SGC7901Luc and MKN28 were infected with lenti-miR-19a, lenti-miR19b or lenti-NC, according to the manufacturer's instructions, and stable cells were isolated by flow cytometry to sort EGFP-positive cells using flow cytometry.
Cell migration and invasion assays. Transwell migration and invasion assays were performed as described before. 30 The invasion assay was performed with Matrigel (BD Biosciences, Sparks, MD, USA) coated on the upper surface of the transwell chamber (Corning, Lowell, MA, USA). Cells that invaded or migrated through the membrane were fixed with methanol and stained with crystal violet. Photographs of four randomly selected fields of the fixed cells were taken and counted. Each experiment was repeated independently three times.
Animals and the in vivo metastasis assay. BALB/C nude mice at 4-6 weeks of age were handled using the best humane practices and cared for in accordance with NIH Animal Care Institutional Guidelines in the Experiment Animal Centre of the Fourth Military Medical University (Xi'an, Shaanxi Province, China). Firefly luciferase-labelled SGC7901 cells-SGC7901Luc were infected with lenti-miR-19a, lenti-miR-19b or lenti-NC, respectively, as described above, and stable clones were isolated. For in vivo metastasis assay, 2 Â 10 6 cells were injected into the caudal veins of each nude mouse. Each group (miR-19a group, miR-19b group and NC group) contained six mice. After injection, bioluminescent signals were detected twice a week by the IVIS 100 Imaging System (Xenogen). Five minutes before imaging, the mice were injected intraperitoneally with 100 mg/kg D-luciferin. The mice were sacrificed seven weeks after injection of gastric cancer cells. For histological analysis, the lungs and livers of nude mice were harvested and fixed in 10% formalin before paraffin embedding, and then were sectioned and stained using H&E staining.
Reporter gene assay. For the reporter gene assay, cells were plated in 12-well plates and were transfected with 2 mg of MXD1 3 0 -UTR luciferase reporter plasmids (S) or the MXD1 3 0 -UTR antisense mutant (AS) and the empty pGL3-Control vector (Promega Biotech Co., Ltd, Beijing, China) using lipofectamine 2000 (Invitrogen). Cells were also cotransfected with the pre-miRNAs (150 nM, Applied Biosystems, Invitrogen). Assays were performed 24 h after transfection using the Dual Luciferase Reporter Assay system (Promega Biotech Co., Ltd). Firefly luciferase activities were normalised to Renilla luciferase activities. A miRNA precursor molecule control from Applied Biosystems (Invitrogen) was used as one of the negative miRNA controls and was referred to as pre-miR-NC. All experiments were performed in triplicate.
Western blot analysis. To determine the levels of protein expression, log phase cells were harvested from 90 mm culture plates, lysed in RIPA lysis buffer (150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 0.1% SDS, 2 mM EDTA, 1 mM PMSF, 1% NP40, 5 mg/ml aprotinin and 1 mg/ml leupeptin) on ice, and then centrifuged at 12000 rpm for 10 min. Total proteins were resolved by 12% SDS-PAGE (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and blotted onto nitrocellulose membranes (Amersham Biosciences Corp., Pittsburgh, PA, USA). Membranes were blocked with 10% non-fat milk powder at room temperature for 2 h and incubated overnight with primary antibodies: anti-MXD1 (1 : 1000; Abcam plc, Cambridge, MA, USA), anti-c-Myc (1 : 1000; Abcam plc) or anti-b-actin antibody (1 : 2000; Sigma-Aldrich Co., St. Louis, MO, USA). After three 5 min washes in triethanolamine-buffered saline solution with 0.1% Tween-20, membranes were incubated with horseradish peroxidase (HRP) conjugated secondary antibodies (1 : 2000; Santa Cruz biotechnology, Inc., Dallas, TX, USA) for 4 h at room temperature and then washed again in TBS-T and visualised with an enhanced chemi-luminescence kit (ECL-kit, Santa Cruz Biotechnology, Inc.). All experiments were performed in triplicate.
